Serologic study of human parvovirus B19 infection in pregnancy in Japan

Journal of Infection

Volumn 38, Issue 1, 1999, Pages 30-35

  Yaegashi, N ^a   Niinuma, T ^a   Chisaka, H ^a   Uehara, S ^a   Okamura, K ^a   Shinkawa, O ^b   Tsunoda, A ^c   Moffatt, S ^a   Sugamura, Kazuo ^a   Yajima, A ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sendai Red Cross Hospital   (Japan)

^c Taihaku Health Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; FETUS HYDROPS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY; SEROPREVALENCE;

EID: 13044305865     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90026-9     Document Type: Article

References (35)

1. Brown KE, Young NS, Parvovirus B19 in human disease. Annu Rev Med 1997; 48: 59-67.
2. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Survey 1997; 52: 254-259.
3. Schwartz TE, Nerlich A, Roggendorf M. Parvovirus B19 infection in pregnancy. Behring Inst Mitt 1990; 85: 69 73.
4. Schwartz TF, Nerlich A, Roggendorff G. et al. Parvovirus B19 infection in pregnancy. Int J Exp Clin Chemother 1990; 3: 219-223.
5. Gratacos E, Torres P-J, Vidal J. et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171: 1360 1363.
6. Hall SM. Public Health Laboratory Service working party on fifth disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990; 300: 1166-1170.
7. Centers for Disease Control. Risks associated with human parvovirus B19 infection. MMWR 1989; 38: 81-97.
8. Guidozzi F, Ballot D, Rothberg AD, Human B19 parvovirus infection in an obstetric population. J Reprod Med 1994; 39: 36-38.
9. Rodis JF, Quinn DL, Gary GW, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study. Am J Obstet Gynecol 1990; 163: 1168 1171.
10. Schoub BD Blackburn NK, Johnson S, McAnerney JM, Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. S Afr Med J 1993; 83: 505-506.
11. Enders G, Biber M, Parvovirus B19 infections in pregnancy. Behring Inst Mitt 1990; 85: 74-78.
12. Miller E, Fairley CK, Cohen BJ, Seng G, Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynecol 1998; 105: 174 178.
13. Morey AL, Porter HJ, Keeling JW, Fleming KA. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection. J Clin Pathol 1992; 45: 673-678.
14. Morey AL, Keeling JW, Porter HJ, Fleming KA, Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynecol 1992; 99: 566-574.
15. Morey AL, O'Neill HJ, Coyle PV, Fleming Immunohistological detection of human parvovirus B19 in formalin-fixed, paraflinembedded tissues. J Pathol 1992; 166: 105 108.
16. Rogers BB, Mark Y, Oyer CE, Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I, Histology. Pediatric Pathol 1993; 13: 371-379.
17. Yaegashi N, Okamura K, Yajima A, Murai C, Sugamura K, The frequency of human parvovirus B19 infection in noniummune hydrops fetalis. J Perinat Med 1994; 22: 159-163.
18. Cubel RCN, Garcia AGP, Pegado CS, et al. Human parvovirus B19 infection and hydrops fetal in Rio de Jeneiro, Brazil. Ment Inst Oswaldo Cruz. Rio de Janeiro 1996; 91: 147 151.
19. Jordan JA, Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996; 174: 37-42.
20. Wright C, Hincheliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynecol 1996; 103: 133-136.
21. Porter HJ, Khong TY, Evans MF, Chan VT-W. Fleming KA. Parvovirus as a cause of hydrops fetalis: detection by in situ. DNA hybridisation. J Clin Pathol 1988; 41: 381-383.
22. Maeda H, Koyanagi T, Nakano H. Intrauterine treatment on non-immune hydrops fetalis. Early Hum Develop 1992; 29: 241-249.
23. Mark Y, Rogers BB, Oyer CE, Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II.DNA amplification. Pediatric Pathol 1993; 13: 381-386.
24. Schwarz TF, Nerlich A, Hillemanns P. Detection of parvovirus B19 in fetal autopsies. Arch Gynecol Obstet 1993; 253: 207-213.
25. Cubie HA, Grzybowski J, da Silva C, Duncan L, Brown T. Smith NM. Synthetic oligonucleotide cocktails as probes for detection of human parvovirus B19. J Virol Methods 1995; 53: 91-102.
26. Yaegashi N, Okamura K, Tsunoda A, Nakamura M, Sugamura K, Yajima A. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19. J Infect 1995; 31: 195-200.
27. Tolfvenstam T, Ruden U, Broliden K, Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Laboratory Immunol 1996; 5: 147-150.
28. Cohen BJ, Bates CN. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Methods 1995; 55: 11-25.
29. Morey AL, Ferguson DJP, Fleming KA, Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis. J Pathol 1993; 169: 213-220.
30. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 non-structural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998; 72: 3018-3028.
31. Yaegashi N, Shiraishi H, Takashita T, Nakamura M, Yajima A, Sugamura K, Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 1989; 63: 2422-2426.
32. Christensen J, Cotmore SF, Tattersall P. Parvovirus initiation factor PIF: a novel human DNA-binding factor coordinate recognizes two ACGT motifs. J Virol 1997; 71: 5733-5741.
33. Christensen J, Cotmore SF, Tattersall P. A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptie to initiate parvovirus DNA replication. J Virol 1997; 71: 1404-1416.
34. Anouja F, Wattiez R, Mouset S, Caillet-Fauquet P. The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. J Virol 1997; 71: 4671-4678.
35. Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 1992; 45: 49-58.